Minted: - / 5000

1242 Sivifene
d7ebf55a387c53528b56d2fd3b5a0e68fa74cf059d3686ebcb7c8032536ee789

Properties

Background

Brown
Bottle

Red
Cap

Blue
Syringe

Purple
Bubbles
No
Drops
Yes
Label
Pill

Chemistry

Formula
C19H14N4O6
Carbon
19
Polarity
Neutral

Sivifene (INN, USAN; developmental code name A-007) is a small-molecule antineoplastic agent and immunomodulator that was under development in the 2000s by Tigris Pharmaceuticals (now Kirax Corporation) as a topical treatment for cutaneous cancer metastases. It was specifically being investigated to treat high-grade squamous intraepithelial lesions (HSIL) associated with human papillomavirus (HPV) infection and invasive carcinomas of the anogenital area such as cervical, vaginal, and anal cancers. The drug reached phase II clinical trials prior to its discontinuation.

From Wikipedia, the free encyclopedia. License: CC BY-SA.